227 related articles for article (PubMed ID: 22982308)
21. Exploring chemical modifications for siRNA therapeutics: a structural and functional outlook.
Shukla S; Sumaria CS; Pradeepkumar PI
ChemMedChem; 2010 Mar; 5(3):328-49. PubMed ID: 20043313
[TBL] [Abstract][Full Text] [Related]
22. Modified siRNAs for the study of the PAZ domain.
Somoza A; Terrazas M; Eritja R
Chem Commun (Camb); 2010 Jun; 46(24):4270-2. PubMed ID: 20485810
[TBL] [Abstract][Full Text] [Related]
23. RNA interference induced by siRNAs modified with 4'-thioribonucleosides in cultured mammalian cells.
Hoshika S; Minakawa N; Kamiya H; Harashima H; Matsuda A
FEBS Lett; 2005 Jun; 579(14):3115-8. PubMed ID: 15919084
[TBL] [Abstract][Full Text] [Related]
24. Identification of sequence features that predict competition potency of siRNAs.
Li X; Yoo JW; Lee JH; Hahn Y; Kim S; Lee DK
Biochem Biophys Res Commun; 2010 Jul; 398(1):92-7. PubMed ID: 20558136
[TBL] [Abstract][Full Text] [Related]
25. Modification of the siRNA passenger strand by 5-nitroindole dramatically reduces its off-target effects.
Zhang J; Zheng J; Lu C; Du Q; Liang Z; Xi Z
Chembiochem; 2012 Sep; 13(13):1940-5. PubMed ID: 22887813
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and silencing properties of siRNAs possessing lipophilic groups at their 3'-termini.
Ueno Y; Kawada K; Naito T; Shibata A; Yoshikawa K; Kim HS; Wataya Y; Kitade Y
Bioorg Med Chem; 2008 Aug; 16(16):7698-704. PubMed ID: 18644731
[TBL] [Abstract][Full Text] [Related]
27. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
Aigner A
J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079
[TBL] [Abstract][Full Text] [Related]
28. Focusing on RISC assembly in mammalian cells.
Hong J; Wei N; Chalk A; Wang J; Song Y; Yi F; Qiao RP; Sonnhammer EL; Wahlestedt C; Liang Z; Du Q
Biochem Biophys Res Commun; 2008 Apr; 368(3):703-8. PubMed ID: 18252196
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and silencing properties of siRNAs possessing lipophilic groups at their 3'-termini.
Ueno Y; Kawada K; Shibata A; Yoshikawa K; Wataya Y; Kitade Y
Nucleic Acids Symp Ser (Oxf); 2008; (52):503-4. PubMed ID: 18776474
[TBL] [Abstract][Full Text] [Related]
30. Improving RNA interference in mammalian cells by 4'-thio-modified small interfering RNA (siRNA): effect on siRNA activity and nuclease stability when used in combination with 2'-O-alkyl modifications.
Dande P; Prakash TP; Sioufi N; Gaus H; Jarres R; Berdeja A; Swayze EE; Griffey RH; Bhat B
J Med Chem; 2006 Mar; 49(5):1624-34. PubMed ID: 16509579
[TBL] [Abstract][Full Text] [Related]
31. Allele-specific silencing by RNA interference.
Hohjoh H
Methods Mol Biol; 2010; 623():67-79. PubMed ID: 20217544
[TBL] [Abstract][Full Text] [Related]
32. RNA interference with 2',4'-bridged nucleic acid analogues.
Abdur Rahman SM; Sato H; Tsuda N; Haitani S; Narukawa K; Imanishi T; Obika S
Bioorg Med Chem; 2010 May; 18(10):3474-80. PubMed ID: 20427190
[TBL] [Abstract][Full Text] [Related]
33. Conjugating phosphospermines to siRNAs for improved stability in serum, intracellular delivery and RNAi-mediated gene silencing.
Paris C; Moreau V; Deglane G; Karim L; Couturier B; Bonnet ME; Kedinger V; Messmer M; Bolcato-Bellemin AL; Behr JP; Erbacher P; Lenne-Samuel N
Mol Pharm; 2012 Dec; 9(12):3464-75. PubMed ID: 23148419
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and properties of modified siRNA having amide-linked oligoribonucleosides at their 3' overhang regions.
Iwase R; Miyao H; Toyama T; Nishimori K
Nucleic Acids Symp Ser (Oxf); 2006; (50):175-6. PubMed ID: 17150874
[TBL] [Abstract][Full Text] [Related]
35. Gene-silencing properties of siRNAs that contain internal amide-bond linkages.
Gong W; Desaulniers JP
Bioorg Med Chem Lett; 2012 Nov; 22(22):6934-7. PubMed ID: 23062704
[TBL] [Abstract][Full Text] [Related]
36. Effect of asymmetric terminal structures of short RNA duplexes on the RNA interference activity and strand selection.
Sano M; Sierant M; Miyagishi M; Nakanishi M; Takagi Y; Sutou S
Nucleic Acids Res; 2008 Oct; 36(18):5812-21. PubMed ID: 18782830
[TBL] [Abstract][Full Text] [Related]
37. Development of peptide-oligonucleotide conjugates for regulation of small RNA function.
Yamayoshi A; Momokawa D; Kobori A; Murakami A
Nucleic Acids Symp Ser (Oxf); 2009; (53):53-4. PubMed ID: 19749256
[TBL] [Abstract][Full Text] [Related]
38. Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells.
Chiu YL; Ali A; Chu CY; Cao H; Rana TM
Chem Biol; 2004 Aug; 11(8):1165-75. PubMed ID: 15324818
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, RNAi activity and nuclease-resistant properties of apolar carbohydrates siRNA conjugates.
Vengut-Climent E; Terrazas M; Lucas R; Arévalo-Ruiz M; Eritja R; Morales JC
Bioorg Med Chem Lett; 2013 Jul; 23(14):4048-51. PubMed ID: 23764303
[TBL] [Abstract][Full Text] [Related]
40. RNA interference using boranophosphate siRNAs: structure-activity relationships.
Hall AH; Wan J; Shaughnessy EE; Ramsay Shaw B; Alexander KA
Nucleic Acids Res; 2004; 32(20):5991-6000. PubMed ID: 15545637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
